Abstract 2861
Background
Chromogranin A, the most frequently used circulating biomarker for diagnosis and follow-up of pancreatic neuroendocrine tumor (PNET) patients, has several limitations. Research in other tumor types has indicated the biomarker potential of circulating tumor DNA (ctDNA). However, ctDNA remains unexplored in PNETs. In this study, we aimed to detect and profile ctDNA in plasma of PNET patients.
Methods
Tumor tissue, perioperative blood samples and clinicopathological data were prospectively collected from 10 PNET patients undergoing surgery for their primary tumor at the Antwerp University Hospital. An additional blood sample was collected from one case during follow-up, when patient had disease progression. Whole exome sequencing was performed on tumor and germline DNA to identify somatic variants and copy number alterations (CNAs). For every patient a somatic single nucleotide variant (SNV) was selected and a digital droplet PCR assay was developed to detect this SNV in DNA isolated from plasma. Shallow whole genome sequencing (sWGS) was performed on plasma DNA to identify CNAs.
Results
In two patients, the somatic SNV could be detected in the perioperative plasma sample at variant allele fractions (VAFs) of 19% and 21%. Interestingly, both patients had metastatic disease and succumbed within two years after surgery, while the other eight patients presented with localized disease and are currently disease-free. The follow-up plasma sample of one of the positive cases showed an increase in VAF to 57%. Next, sWGS was performed on ctDNA-positive plasma to detect CNAs. A significant correlation (p < 0.01) was found between CNAs in primary tumor and CNAs in perioperative plasma sample. The CNA profile of the follow-up sample showed increased genetic instability.
Conclusions
We provide evidence for the presence of ctDNA in patients with a metastatic PNET. Non-metastatic cases were ctDNA-negative. An increase in VAF and genetic instability were found in the follow-up sample of one of the metastatic cases, suggesting potential for ctDNA as follow-up marker. Furthermore, CNAs in primary tumor and plasma sample were significantly correlated, proposing ctDNA as an alternative for molecular profiling of tissue in metastatic patients.
Clinical trial identification
Legal entity responsible for the study
Antwerp University Hospital.
Funding
Kom op tegen Kanker (Stand up to Cancer), the Flemish cancer society; Research Foundation – Flanders (FWO).
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
4162 - ODM-207 - a novel BET bromodomain inhibitor with antitumor activity in nonclinical models of ER+ breast cancer
Presenter: Anu Moilanen
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3747 - HER2-positive breast cancer resistance to trastuzumab is associated with metabolic switch.
Presenter: Roman Dubianski
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4688 - Combination treatment with the PARP inhibitor niraparib and chemotherapeutics in a preclinical model of KRAS/BRAF mutated colorectal cancer cell lines across the four Consensus Molecular Subtypes.
Presenter: Pietro Paolo Vitiello
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
498 - Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway.
Presenter: Xiao Fu
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3731 - Effect of the polymorphism rs2470893 of the CYP1A1 gene on ovarian and endometrial cancer in Mediterranean women
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1215 - Cisplatin in NIPEC or HIPEC?
Presenter: Ivan Alvovsky
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
2738 - Matrix metalloproteinase-mediated regulation of programmed-death ligand in the human head and neck squamous cell carcinoma microenvironment
Presenter: MARIKO HIRAI
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
2190 - Trametinib synergizes with dexamethasone in KRAS-mutant myeloma cell lines through modulation of NDRG1 and induction of apoptosis
Presenter: Priya Sriskandarajah
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4482 - Functional inhibition of TGF-_ in colorectal cancer cells and its interaction with AXL receptor
Presenter: Davide Ciardiello
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
624 - Isoform-specific AKT Inhibition Differentially Affects Cell Functions in Pancreatic Adenocarcinoma
Presenter: Hugo Arasanz
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract